Enovis Balance Sheet Health
Financial Health criteria checks 3/6
Enovis has a total shareholder equity of $3.3B and total debt of $1.3B, which brings its debt-to-equity ratio to 40.4%. Its total assets and total liabilities are $5.6B and $2.2B respectively. Enovis's EBIT is $29.4M making its interest coverage ratio 0.6. It has cash and short-term investments of $35.4M.
Key information
40.4%
Debt to equity ratio
US$1.35b
Debt
| Interest coverage ratio | 0.6x |
| Cash | US$35.43m |
| Equity | US$3.33b |
| Total liabilities | US$2.22b |
| Total assets | US$5.55b |
Recent financial health updates
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Sep 24
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Jun 07Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Recent updates
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Sep 24It's A Story Of Risk Vs Reward With Enovis Corporation (NYSE:ENOV)
Aug 20Enovis Languishing Despite Respectable Performance
Jul 15Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Jun 07Enovis: Solid Growth, But Unstable Financial Footing
May 05Enovis Corporation (NYSE:ENOV) Might Not Be As Mispriced As It Looks
Apr 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Feb 12Is Enovis (NYSE:ENOV) Using Too Much Debt?
Jan 14Investors Holding Back On Enovis Corporation (NYSE:ENOV)
Dec 18Calculating The Fair Value Of Enovis Corporation (NYSE:ENOV)
Nov 05Enovis Making Good Choices, But Not Seeing The Rewards
Sep 27Is Enovis (NYSE:ENOV) A Risky Investment?
Sep 22Estimating The Intrinsic Value Of Enovis Corporation (NYSE:ENOV)
Aug 03Enovis Corporation: Things Are Looking Good As Guidance Is Raised
Jul 18We Think Enovis (NYSE:ENOV) Has A Fair Chunk Of Debt
Jun 20Enovis Corporation Q4 2022 Earnings Preview
Feb 22Is Enovis (NYSE:ENOV) A Risky Investment?
Feb 22Is Enovis Corporation (NYSE:ENOV) Worth US$60.5 Based On Its Intrinsic Value?
Jan 25Enovis Corporation reports Q3 earnings beat; updates FY22 guidance
Nov 02Is Enovis (NYSE:ENOV) A Risky Investment?
Oct 19Is Enovis Corporation (NYSE:ENOV) Trading At A 27% Discount?
Sep 14Enovis launches augmented reality system ARVIS for use in hip, knee surgery
Jul 19Here's Why Enovis (NYSE:ENOV) Can Manage Its Debt Responsibly
Jul 05Enovis announces CFO transition
Jun 30Enovis: Medtech Leftover Of Colfax With Some To Prove
May 23As The Colfax Chapter Ends, Both ESAB And Enovis Have Something To Prove
Apr 05Financial Position Analysis
Short Term Liabilities: ENOV's short term assets ($1.2B) exceed its short term liabilities ($530.2M).
Long Term Liabilities: ENOV's short term assets ($1.2B) do not cover its long term liabilities ($1.7B).
Debt to Equity History and Analysis
Debt Level: ENOV's net debt to equity ratio (39.3%) is considered satisfactory.
Reducing Debt: ENOV's debt to equity ratio has reduced from 128.7% to 40.4% over the past 5 years.
Debt Coverage: ENOV's debt is not well covered by operating cash flow (7%).
Interest Coverage: ENOV's interest payments on its debt are not well covered by EBIT (0.6x coverage).